95 related articles for article (PubMed ID: 31699190)
1. [Correlation between Methylation of SALL3 and Cervical Cancer].
Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
[TBL] [Abstract][Full Text] [Related]
4. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
5. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of
Misawa K; Mochizuki D; Imai A; Misawa Y; Endo S; Mima M; Kawasaki H; Carey TE; Kanazawa T
Clin Epigenetics; 2017; 9():64. PubMed ID: 28616099
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
Li M; Li O; Sun J; Zheng X; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
[No Abstract] [Full Text] [Related]
8. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
[TBL] [Abstract][Full Text] [Related]
9. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
[TBL] [Abstract][Full Text] [Related]
10. Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Zhang L; Hu D; Wang S; Zhang Y; Pang L; Tao L; Jia W
Gene; 2020 Jan; 723():144142. PubMed ID: 31589957
[TBL] [Abstract][Full Text] [Related]
11. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
[TBL] [Abstract][Full Text] [Related]
12. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
[TBL] [Abstract][Full Text] [Related]
13. Promoter Methylation and Relative mRNA Expression of the p16 Gene in Cervical Cancer in North Indians.
Gupta A; Ahmad MK; Mahndi AA; Singh R; Pradeep Y
Asian Pac J Cancer Prev; 2016; 17(8):4149-54. PubMed ID: 27644676
[TBL] [Abstract][Full Text] [Related]
14. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
15. IGSF4 promoter methylation and expression silencing in human cervical cancer.
Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Cheng HY; Chen XW; Cheng L; Liu YD; Lou G
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1821-5. PubMed ID: 20213097
[TBL] [Abstract][Full Text] [Related]
17. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
Song Y; Zhang C
Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
[TBL] [Abstract][Full Text] [Related]
18. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization.
Bai LX; Wang JT; Ding L; Jiang SW; Kang HJ; Gao CF; Chen X; Chen C; Zhou Q
Asian Pac J Cancer Prev; 2014; 15(21):9313-7. PubMed ID: 25422218
[TBL] [Abstract][Full Text] [Related]
19. Study on the methylation status of SPINT2 gene and its expression in cervical carcinoma.
Wang N; Che Y; Yin F; Yu F; Bi X; Wang Y
Cancer Biomark; 2018; 22(3):435-442. PubMed ID: 29843210
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]